{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:11:43Z","timestamp":1791295903162,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Metabrain Research"},{"DOI":"10.13039\/501100004794","name":"CNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005736","name":"University Paris-Diderot","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005736","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.bbadis.2015.02.001","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T11:36:50Z","timestamp":1423481810000},"page":"980-991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Expression of the kynurenine pathway enzymes in the pancreatic islet cells. Activation by cytokines and glucolipotoxicity"],"prefix":"10.1016","volume":"1852","author":[{"given":"J.J.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Raynal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bailb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gausseres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Carbonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Autier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Movassat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kergoat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Portha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbadis.2015.02.001_bb0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1440-1711.2003.t01-1-01177.x","article-title":"Tryptophan and the immune response","volume":"81","author":"Moffett","year":"2003","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrd870","article-title":"Endogenous kynurenines as targets for drug discovery and development","volume":"1","author":"Stone","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1468-1331.2006.01220.x","article-title":"Tryptophan metabolism and oxidative stress in patients with chronic brain injury","volume":"13","author":"Mackay","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406000068","article-title":"Tryptophan metabolism in the central nervous system: medical implications","volume":"8","author":"Ruddick","year":"2006","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ijc.2910600117","article-title":"The role of indoleamine 2,3-dioxygenase in the antitumour activity of human interferon-gamma in vivo","volume":"60","author":"Burke","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0030","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S","article-title":"Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma independent mechanism","volume":"31","author":"Fujigaki","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0035","first-page":"112","article-title":"beta amyloid peptide 1-42 induces human macrophages to produce the neurotoxin quinolinic acid","volume":"118","author":"Guillemin","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0040","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood-2006-07-034785","article-title":"HIV-1 inhibits CD4+ T cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells","volume":"109","author":"Boasso","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/187153006778250019","article-title":"Targeting tumor-related immunosuppression for cancer immunotherapy","volume":"6","author":"Frumento","year":"2006","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0050","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1128\/JVI.74.9.4110-4115.2000","article-title":"Induction of indolamine 2,3-dioxygenase in primary human macrophages by human immunodeficiency virus type 1 is strain dependent","volume":"74","author":"Grant","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0055","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1021\/ja01593a069","article-title":"Reduced triphophopyridine-nucleotide requirement for the enzymatic formation of 3-hydroxykynurenine from L-kynurenine","volume":"78","author":"De Castro","year":"1956","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0060","first-page":"135","article-title":"Enzymology of NAD+ synthesis","volume":"73","author":"Magni","year":"1999","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0065","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.0013-9580.2004.65203.x","article-title":"NMDA preconditioning protects against seizures and hippocampal neurotoxicity induced by quinolinicacid in mice","volume":"45","author":"Boeck","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.brainres.2005.11.033","article-title":"Kynurenic acid attenuates NMDA induced pial arteriolar dilation in newborn pigs","volume":"1069","author":"Bari","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0165-3806(92)90256-V","article-title":"Developmental changes in brain kynurenic acid concentrations","volume":"68","author":"Beal","year":"1992","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0080","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0306-4522(85)90063-6","article-title":"Quinolinic acid and other kynurenines in the central nervous system","volume":"15","author":"Stone","year":"1985","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0085","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","article-title":"Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer`s disease hippocampus","volume":"31","author":"Guillemin","year":"2005","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0090","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.schres.2005.07.013","article-title":"Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia","volume":"80","author":"Nilsson","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0095","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0304-3940(01)02242-X","article-title":"Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia","volume":"313","author":"Erhardt","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0110","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1469-7610.2010.02245.x","article-title":"The possible role of the kynurenine pathway in adolescent depression with melancholic features","volume":"51","author":"Gabbay","year":"2010","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2005.12.056","article-title":"Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder","volume":"1074","author":"Miller","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1503\/jpn.090180","article-title":"Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder","volume":"35","author":"Olsson","year":"2010","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0130","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nature13323","article-title":"Aryl hydrocarbon receptor control of a disease tolerance defence pathway","volume":"511","author":"Bessede","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0135","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1073\/pnas.81.3.908","article-title":"Interferon gamma blocks the growth of Toxoplasmagondii in human fibroblasts by inducing the host cells to degrade tryptophan","volume":"81","author":"Pfefferkorn","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0140","doi-asserted-by":"crossref","first-page":"e14698","DOI":"10.1371\/journal.pone.0014698","article-title":"Interferon-gamma regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO)","volume":"6","author":"Croitoru-Lamoury","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0145","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1111\/j.1742-4658.2011.08366.x","article-title":"Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats","volume":"278","author":"Braidy","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0150","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0155","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.1523\/JNEUROSCI.4101-07.2007","article-title":"Characterization of the kynurenine pathway inhuman neurons","volume":"27","author":"Guillemin","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0160","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1365-2826.1995.tb00741.x","article-title":"Dexamethasone regulates the expression of neuronal properties of a rat insulinoma cell line","volume":"7","author":"Atouf","year":"1995","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0165","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1074\/jbc.272.3.1929","article-title":"Expression of neuronal traits in pancreatic \u03b2-cells. Implication of neuron-restrictive silencing factor\/repressor element silencing transcription factor, a neuron-restrictive silencer","volume":"272","author":"Atouf","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0170","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cmet.2013.05.001","article-title":"Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity","volume":"17","author":"Donath","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0175","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1152\/ajpregu.00373.2011","article-title":"Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone","volume":"303","author":"Wolowczuk","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0180","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2337\/db06-0617","article-title":"Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human islets","volume":"56","author":"Sarkar","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0185","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.molmed.2013.02.007","article-title":"Tryptophan metabolism: entering the field of aging and age-related pathologies","volume":"19","author":"Van der Goot","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0190","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1152\/ajpendo.90871.2008","article-title":"Diabetic GK\/Par rat beta-cells are spontaneously protected against H2O2-triggered apoptosis. A cAMP-dependent adaptive response","volume":"298","author":"Lacraz","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0195","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2337\/diab.31.4.299","article-title":"Sorting of pancreatic islet cell subpopulations by light scattering using a fluorescence activated cell sorter","volume":"31","author":"Nielsen","year":"1982","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0200","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0006-291X(83)90857-4","article-title":"Autofluorescence-activated cell sorting ofpancreatic islet cells: purification of insulin-containing \u0392-cells according to glucose-induced changes in cellular redox state","volume":"114","author":"Van De Winkel","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0205","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/BJ20101386","article-title":"Ceramide synthase 4 and de novo production of ceramides with specific N-acyl chain lengths are involved in glucolipotoxicity-induced apoptosis of INS-1 \u03b2-cells","volume":"438","author":"V\u00e9ret","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0210","series-title":"International Congress Series 1304","article-title":"Characterization of the kynurenine pathway in human oligodendrocytes","author":"Lim","year":"2007"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0215","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1007\/s00125-005-1839-7","article-title":"Global profiling of coxsackie virus- and cytokine-induced gene expression in human pancreatic islets","volume":"48","author":"Ylipaasto","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-9255-8-25","article-title":"Effects of pro-inflammatory cytokines on expression of kynurenine pathway enzymes in human dermal fibroblasts","volume":"8","author":"Asp","year":"2011","journal-title":"J. Inflamm. (Lond.)"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0225","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/npp.2011.277","article-title":"Interleukin-1\u03b2: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis","volume":"37","author":"Zunszain","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2009.05356.x","article-title":"Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism","volume":"1199","author":"Oxenkrug","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0235","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/bj3260351","article-title":"Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types","volume":"326","author":"Heyes","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0240","doi-asserted-by":"crossref","first-page":"e58767","DOI":"10.1371\/journal.pone.0058767","article-title":"Expression and regulation of nampt in human islets","volume":"8","author":"Kover","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0245","doi-asserted-by":"crossref","first-page":"e54106","DOI":"10.1371\/journal.pone.0054106","article-title":"The adipocytokine Nampt and its product NMN have no effect on \u03b2-cell survival but potentiate glucose stimulated insulin secretion","volume":"8","author":"Spinnler","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbadis.2015.02.001_bb0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnins.2014.00012","article-title":"Kynurenines in CNS disease: regulation by inflammatory cytokines","volume":"8","author":"Campbell","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0255","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0260","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1084\/jem.20020052","article-title":"Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase- expressing dendritic cells: mediation of suppression by tryptophan metabolites","volume":"196","author":"Terness","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2015.02.001_bb0265","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3181\/00379727-178-42010","article-title":"3-Hydroxykynurenine, 3-hydroxyanthranilic acid, and o-aminophenol inhibit leucine-stimulated insulin release from rat pancreatic islets","volume":"178","author":"Rogers","year":"1985","journal-title":"Proc. Soc. Exp. Biol. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443915000526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443915000526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T06:20:15Z","timestamp":1537856415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443915000526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0925443915000526"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2015.02.001","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of the kynurenine pathway enzymes in the pancreatic islet cells. Activation by cytokines and glucolipotoxicity","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2015.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}